# Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response

> **NCT00841100** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 21 (actual)

## Conditions studied

- Phenylketonuria

## Interventions

- **DRUG:** Kuvan
- **OTHER:** Diet

## Key facts

- **NCT ID:** NCT00841100
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-07-19
- **Final completion:** 2011-07-19
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841100, "Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00841100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*